Soligenix, Inc. (SNGX) — DEF 14A Filings
All DEF 14A filings from Soligenix, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Soligenix Files Definitive Proxy Statement for June 20, 2025 Meeting
— May 5, 2025 Risk: low
Soligenix, Inc. filed its definitive proxy statement on May 5, 2025, for its annual meeting of stockholders scheduled for June 20, 2025. The filing outlines the -
Soligenix Advances Rare Disease Pipeline, Focuses on HyBryte™ for CTCL
— Apr 29, 2024 Risk:
SOLIGENIX, INC. (SNGX) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Soligenix is advancing HyBryte™ (synthetic hypericin) as a potential tr
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX